Characteristics of early Paget's disease in SQSTMI mutation carriers: baseline analysis of the ZIPP study cohort

Owen Cronin; Deepak Subedi; Laura Forsyth; Kirsteen Goodman; Steff C. Lewis; Catriona Keerie; Allan Walker; Mary Porteous; Roseanne Cetnarskyj; Lakshminarayan R. Ranganath; Peter Selby; Geeta Hampson; Rama Chandra; Shu Ho; Jonathan H Tobias; Steven Young-Min; Malachi J. McKenna; Rachel K. Crowley; William D Fraser; Jonathan Tang; Luigi Gennari; Rannuccio Nuti; Maria Luisa Brandi; Javier Del Pino-Montes; Jean-Pierre Devogelaer; Anne Durnez; Giovanni Carlo Isaia; Marco Di Stefano; Josep Blanch Rubio; Núria Guañabens; Markus J. Seibel; John P Walsh; Mark A. Kotowicz; Geoffrey C. Nicholson; Emma L Duncan; Gabor Major; Anne Horne; Nigel L. Gilchrist; Stuart H. Ralston

doi:10.1002/jbmr.4007

Characteristics of early Paget's disease in SQSTMI mutation carriers: baseline analysis of the ZIPP study cohort

Owen Cronin, Deepak Subedi, Laura Forsyth, Kirsteen Goodman, Steff C. Lewis, Catriona Keerie, Allan Walker, Mary Porteous, Roseanne Cetnarskyj, Lakshminarayan R. Ranganath, Peter Selby, Geeta Hampson, Rama Chandra, Shu Ho, Jonathan H Tobias, Steven Young-Min, Malachi J. McKenna, Rachel K. Crowley, William D Fraser, Jonathan TangLuigi Gennari, Rannuccio Nuti, Maria Luisa Brandi, Javier Del Pino-Montes, Jean-Pierre Devogelaer, Anne Durnez, Giovanni Carlo Isaia, Marco Di Stefano, Josep Blanch Rubio, Núria Guañabens, Markus J. Seibel, John P Walsh, Mark A. Kotowicz, Geoffrey C. Nicholson, Emma L Duncan, Gabor Major, Anne Horne, Nigel L. Gilchrist, Stuart H. Ralston^*

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

9 Citations (Scopus)

78 Downloads (Pure)

Abstract

Objectives: Mutations in SQSTM1 are strongly associated with Paget’s disease of bone (PDB) but little is known about the clinical characteristics of those with early disease.
Methods: Radionuclide bone scans, biochemical markers of bone turnover and clinical characteristics were analysed in SQSTM1 mutation carriers who took part in the Zoledronic acid in the Prevention of Paget’s disease (ZiPP) study.
Results: We studied 222 individuals of whom 54.9% were female with average (± sem) age of 50.1± 0.6 years. Twelve SQSTM1 mutations were observed, including p.Pro392Leu which was present in 141/222 (63.5%) subjects. Bone scan examination revealed evidence of PDB in 20 subjects (9.0%) of which 9 (50%) had a single affected site. Participants with lesions were older than those without lesions but the difference was not significant (53.6 ± 9.1 vs. 49.8 ± 8.9, p=0.07). The mean age of participants with lesions was not significantly different from the age at which their parents were diagnosed with PDB (55 years vs. 59 years, p=0.25). All individuals with lesions were asymptomatic. Serum concentrations of total alkaline phosphatase (ALP) normalised to the upper limit of normal in each centre were higher in those with lesions (0.75 ± 0.69 vs 0.42 ± 0.29; p<0.0001). Similar findings were observed for other biochemical markers of bone turnover but the sensitivity of ALP and other markers in detecting lesions was poor.
Conclusions: Asymptomatic PDB is present in about 9% of SQSTM1 mutation carriers by the fifth decade. Further follow up of this cohort will provide important information on the natural history of early PDB and its response to treatment

Original language	English
Number of pages	7
Journal	Journal of Bone and Mineral Research
DOIs	https://doi.org/10.1002/jbmr.4007
Publication status	Published - 16 Mar 2020

Keywords

Paget’s disease of bone
radionuclide imaging
SQSTM1
genetics

Access to Document

10.1002/jbmr.4007

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via Wiley at https://doi.org/10.1002/jbmr.4007 . Please refer to any applicable terms of use of the publisher.
Final published version, 609 KBLicence: CC BY

Handle.net

Persistent link

Embargoed Document

Full-text PDF (accepted author manuscript)
Accepted author manuscript, 1.55 MB
Request copy

Cite this

Cronin, O., Subedi, D., Forsyth, L., Goodman, K., Lewis, S. C., Keerie, C., Walker, A., Porteous, M., Cetnarskyj, R., Ranganath, L. R., Selby, P., Hampson, G., Chandra, R., Ho, S., Tobias, J. H., Young-Min, S., McKenna, M. J., Crowley, R. K., Fraser, W. D., ... Ralston, S. H. (2020). Characteristics of early Paget's disease in SQSTMI mutation carriers: baseline analysis of the ZIPP study cohort. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.4007

@article{8e2aa5f825a24940a42bb2977bdf9899,

title = "Characteristics of early Paget's disease in SQSTMI mutation carriers: baseline analysis of the ZIPP study cohort",

abstract = "Objectives: Mutations in SQSTM1 are strongly associated with Paget{\textquoteright}s disease of bone (PDB) but little is known about the clinical characteristics of those with early disease. Methods: Radionuclide bone scans, biochemical markers of bone turnover and clinical characteristics were analysed in SQSTM1 mutation carriers who took part in the Zoledronic acid in the Prevention of Paget{\textquoteright}s disease (ZiPP) study. Results: We studied 222 individuals of whom 54.9% were female with average (± sem) age of 50.1± 0.6 years. Twelve SQSTM1 mutations were observed, including p.Pro392Leu which was present in 141/222 (63.5%) subjects. Bone scan examination revealed evidence of PDB in 20 subjects (9.0%) of which 9 (50%) had a single affected site. Participants with lesions were older than those without lesions but the difference was not significant (53.6 ± 9.1 vs. 49.8 ± 8.9, p=0.07). The mean age of participants with lesions was not significantly different from the age at which their parents were diagnosed with PDB (55 years vs. 59 years, p=0.25). All individuals with lesions were asymptomatic. Serum concentrations of total alkaline phosphatase (ALP) normalised to the upper limit of normal in each centre were higher in those with lesions (0.75 ± 0.69 vs 0.42 ± 0.29; p<0.0001). Similar findings were observed for other biochemical markers of bone turnover but the sensitivity of ALP and other markers in detecting lesions was poor. Conclusions: Asymptomatic PDB is present in about 9% of SQSTM1 mutation carriers by the fifth decade. Further follow up of this cohort will provide important information on the natural history of early PDB and its response to treatment",

keywords = "Paget{\textquoteright}s disease of bone, radionuclide imaging, SQSTM1, genetics",

author = "Owen Cronin and Deepak Subedi and Laura Forsyth and Kirsteen Goodman and Lewis, {Steff C.} and Catriona Keerie and Allan Walker and Mary Porteous and Roseanne Cetnarskyj and Ranganath, {Lakshminarayan R.} and Peter Selby and Geeta Hampson and Rama Chandra and Shu Ho and Tobias, {Jonathan H} and Steven Young-Min and McKenna, {Malachi J.} and Crowley, {Rachel K.} and Fraser, {William D} and Jonathan Tang and Luigi Gennari and Rannuccio Nuti and Brandi, {Maria Luisa} and {Del Pino-Montes}, Javier and Jean-Pierre Devogelaer and Anne Durnez and Isaia, {Giovanni Carlo} and {Di Stefano}, Marco and Rubio, {Josep Blanch} and N{\'u}ria Gua{\~n}abens and Seibel, {Markus J.} and Walsh, {John P} and Kotowicz, {Mark A.} and Nicholson, {Geoffrey C.} and Duncan, {Emma L} and Gabor Major and Anne Horne and Gilchrist, {Nigel L.} and Ralston, {Stuart H.}",

year = "2020",

month = mar,

day = "16",

doi = "10.1002/jbmr.4007",

language = "English",

journal = "Journal of Bone and Mineral Research",

issn = "0884-0431",

publisher = "Wiley",

}

Cronin, O, Subedi, D, Forsyth, L, Goodman, K, Lewis, SC, Keerie, C, Walker, A, Porteous, M, Cetnarskyj, R, Ranganath, LR, Selby, P, Hampson, G, Chandra, R, Ho, S, Tobias, JH, Young-Min, S, McKenna, MJ, Crowley, RK, Fraser, WD, Tang, J, Gennari, L, Nuti, R, Brandi, ML, Del Pino-Montes, J, Devogelaer, J-P, Durnez, A, Isaia, GC, Di Stefano, M, Rubio, JB, Guañabens, N, Seibel, MJ, Walsh, JP, Kotowicz, MA, Nicholson, GC, Duncan, EL, Major, G, Horne, A, Gilchrist, NL & Ralston, SH 2020, 'Characteristics of early Paget's disease in SQSTMI mutation carriers: baseline analysis of the ZIPP study cohort', Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.4007

TY - JOUR

T1 - Characteristics of early Paget's disease in SQSTMI mutation carriers

T2 - baseline analysis of the ZIPP study cohort

AU - Cronin, Owen

AU - Subedi, Deepak

AU - Forsyth, Laura

AU - Goodman, Kirsteen

AU - Lewis, Steff C.

AU - Keerie, Catriona

AU - Walker, Allan

AU - Porteous, Mary

AU - Cetnarskyj, Roseanne

AU - Ranganath, Lakshminarayan R.

AU - Selby, Peter

AU - Hampson, Geeta

AU - Chandra, Rama

AU - Ho, Shu

AU - Tobias, Jonathan H

AU - Young-Min, Steven

AU - McKenna, Malachi J.

AU - Crowley, Rachel K.

AU - Fraser, William D

AU - Tang, Jonathan

AU - Gennari, Luigi

AU - Nuti, Rannuccio

AU - Brandi, Maria Luisa

AU - Del Pino-Montes, Javier

AU - Devogelaer, Jean-Pierre

AU - Durnez, Anne

AU - Isaia, Giovanni Carlo

AU - Di Stefano, Marco

AU - Rubio, Josep Blanch

AU - Guañabens, Núria

AU - Seibel, Markus J.

AU - Walsh, John P

AU - Kotowicz, Mark A.

AU - Nicholson, Geoffrey C.

AU - Duncan, Emma L

AU - Major, Gabor

AU - Horne, Anne

AU - Gilchrist, Nigel L.

AU - Ralston, Stuart H.

PY - 2020/3/16

Y1 - 2020/3/16

N2 - Objectives: Mutations in SQSTM1 are strongly associated with Paget’s disease of bone (PDB) but little is known about the clinical characteristics of those with early disease. Methods: Radionuclide bone scans, biochemical markers of bone turnover and clinical characteristics were analysed in SQSTM1 mutation carriers who took part in the Zoledronic acid in the Prevention of Paget’s disease (ZiPP) study. Results: We studied 222 individuals of whom 54.9% were female with average (± sem) age of 50.1± 0.6 years. Twelve SQSTM1 mutations were observed, including p.Pro392Leu which was present in 141/222 (63.5%) subjects. Bone scan examination revealed evidence of PDB in 20 subjects (9.0%) of which 9 (50%) had a single affected site. Participants with lesions were older than those without lesions but the difference was not significant (53.6 ± 9.1 vs. 49.8 ± 8.9, p=0.07). The mean age of participants with lesions was not significantly different from the age at which their parents were diagnosed with PDB (55 years vs. 59 years, p=0.25). All individuals with lesions were asymptomatic. Serum concentrations of total alkaline phosphatase (ALP) normalised to the upper limit of normal in each centre were higher in those with lesions (0.75 ± 0.69 vs 0.42 ± 0.29; p<0.0001). Similar findings were observed for other biochemical markers of bone turnover but the sensitivity of ALP and other markers in detecting lesions was poor. Conclusions: Asymptomatic PDB is present in about 9% of SQSTM1 mutation carriers by the fifth decade. Further follow up of this cohort will provide important information on the natural history of early PDB and its response to treatment

AB - Objectives: Mutations in SQSTM1 are strongly associated with Paget’s disease of bone (PDB) but little is known about the clinical characteristics of those with early disease. Methods: Radionuclide bone scans, biochemical markers of bone turnover and clinical characteristics were analysed in SQSTM1 mutation carriers who took part in the Zoledronic acid in the Prevention of Paget’s disease (ZiPP) study. Results: We studied 222 individuals of whom 54.9% were female with average (± sem) age of 50.1± 0.6 years. Twelve SQSTM1 mutations were observed, including p.Pro392Leu which was present in 141/222 (63.5%) subjects. Bone scan examination revealed evidence of PDB in 20 subjects (9.0%) of which 9 (50%) had a single affected site. Participants with lesions were older than those without lesions but the difference was not significant (53.6 ± 9.1 vs. 49.8 ± 8.9, p=0.07). The mean age of participants with lesions was not significantly different from the age at which their parents were diagnosed with PDB (55 years vs. 59 years, p=0.25). All individuals with lesions were asymptomatic. Serum concentrations of total alkaline phosphatase (ALP) normalised to the upper limit of normal in each centre were higher in those with lesions (0.75 ± 0.69 vs 0.42 ± 0.29; p<0.0001). Similar findings were observed for other biochemical markers of bone turnover but the sensitivity of ALP and other markers in detecting lesions was poor. Conclusions: Asymptomatic PDB is present in about 9% of SQSTM1 mutation carriers by the fifth decade. Further follow up of this cohort will provide important information on the natural history of early PDB and its response to treatment

KW - Paget’s disease of bone

KW - radionuclide imaging

KW - SQSTM1

KW - genetics

U2 - 10.1002/jbmr.4007

DO - 10.1002/jbmr.4007

M3 - Article (Academic Journal)

C2 - 32176830

SN - 0884-0431

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

ER -

Characteristics of early Paget's disease in SQSTMI mutation carriers: baseline analysis of the ZIPP study cohort

Abstract

Keywords

Access to Document

Handle.net

Embargoed Document

Fingerprint

Cite this